HOME >> MEDICINE >> NEWS
More patients would refuse treatment if the outcome were impaired quality of life

New Haven, Conn. More patients would refuse life-sustaining treatment if they knew the outcome would be a life of severe functional or cognitive impairment, according to a study by a Yale researcher published Thursday in the New England Journal of Medicine.

"A central component of quality end of life care is honoring patients preferences," said Terri Fried, M.D., associate professor of internal medicine and geriatrics at Yale School of Medicine and lead author of the article. "If patients preferences are to be honored, they must be well understood. The results of this study suggest that this understanding depends upon an assessment of patients valuations of treatment burdens in relationship to the likelihood of different potential treatment outcomes. Outcomes of functional and cognitive impairment are particularly important to patients preferences, and require explicit consideration in advance care planning."

Studies examining the outcome of mortality demonstrate that its likelihood also affects preferences, but other outcomes have not been similarly examined. The objective of the current study was to examine the effect of treatment burden, a variety of treatment outcomes, and the likelihood of those outcomes on older seriously ill patients preferences for care.

The study included 226 persons 60 years of age or older with a limited life expectancy because of cancer, congestive heart failure, or chronic obstructive pulmonary disease. The participants were asked if they would want to receive a given treatment, first when the outcome was known with certainty, and then with different likely outcomes. The outcome without treatment was specified as dying of the underlying disease.

When the participants were told they could expect low burden treatment with a return to current health, 98.7 percent chose to receive treatment rather than die without it. When the treatment was changed to high burden, 11.2 percent of the 223 participants who
'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
3-Apr-2002


Page: 1 2 3

Related medicine news :

1. Hormonal treatment improves survival in high-risk prostate cancer patients
2. Study finds that coordinating care of chronically ill patients does not increase liability
3. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
4. Optical technique identifies vulnerable plaques in cardiac patients
5. NHS target driven culture is failing patients
6. Cardiac deaths peak in sleep hours for patients with sleep apnea
7. Chronic fatigue patients show lower response to placebos
8. Depression linked to insomnia in HIV patients
9. Disfigured patients may be forced to forego surgery
10. Massive weight loss patients create mass appeal for body contouring procedures
11. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... ... distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in ... and patient safety. Only a few hospitals and facilities have earned this distinction. ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick Taché ... Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is a ... & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011. ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... -- Global Interventional Radiology Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology:
Cached News: